The Next

Building a model and using it to run detailed simulations is one of the best ways to support confident, data-driven decisions in today’s competitive marketplace.

Emerging alternative protein manufacturers and the food tech sector have had to rely on biopharma practices, which inhibit scale up with steep price tags and long production times. Here’s how zero-based equipment can help tailor those practices to achieve commercial scale.

Moving past natural gas and electric boilers can achieve the pharmaceutical industry’s decarbonization goals.

Fully integrated teams, that include strategic trade partners rather than subcontractors, exceed client expectations for safety, quality, cost certainty and speed to market.

Real talk from the front lines of today’s research and manufacturing landscape

The adaptive reuse of existing space for labs is an emerging trend sparked by increased capacity demands, supply chain challenges, and sustainability goals.

Decades of scientific progress in understanding the root cause of many formerly intractable diseases has opened up new treatment options, namely through RNA-based therapies. This second wave of biopharma, in which our understanding of the ways coding portions of our genome relate to disease, allows us to intercede earlier, and at more specific and effective junctures.